Your browser doesn't support javascript.
loading
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial.
Ashina, Messoud; Tepper, Stewart J; Reuter, Uwe; Blumenfeld, Andrew M; Hutchinson, Susan; Xia, Jing; Miceli, Rosa; Severt, Lawrence; Finnegan, Michelle; Trugman, Joel M.
Afiliação
  • Ashina M; Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Tepper SJ; Department of Neurology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • Reuter U; Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Blumenfeld AM; Headache Center of Southern California, Carlsbad, California, USA.
  • Hutchinson S; Orange County Migraine and Headache Center, Irvine, California, USA.
  • Xia J; AbbVie, Madison, New Jersey, USA.
  • Miceli R; AbbVie, Madison, New Jersey, USA.
  • Severt L; AbbVie, Madison, New Jersey, USA.
  • Finnegan M; AbbVie, Madison, New Jersey, USA.
  • Trugman JM; AbbVie, Madison, New Jersey, USA.
Headache ; 63(1): 79-88, 2023 01.
Article em En | MEDLINE | ID: mdl-36651532
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos de Enxaqueca Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos de Enxaqueca Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article